Global NGS-based RNA-sequencing Market Research Report 2023

Report ID: 2009671 | Published Date: Jan 2025 | No. of Page: 98 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Sequencing by Synthesis
        1.2.3 Ion Semiconductor Sequencing
        1.2.4 Single-molecule Real-time Sequencing
        1.2.5 Nanopore Sequencing
    1.3 Market by Application
        1.3.1 Global NGS-based RNA-sequencing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Research & Academia
        1.3.3 Hospitals & Clinics
        1.3.4 Pharmaceutical & Biotechnology Companies
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global NGS-based RNA-sequencing Market Perspective (2017-2028)
    2.2 NGS-based RNA-sequencing Growth Trends by Region
        2.2.1 NGS-based RNA-sequencing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 NGS-based RNA-sequencing Historic Market Size by Region (2017-2022)
        2.2.3 NGS-based RNA-sequencing Forecasted Market Size by Region (2023-2028)
    2.3 NGS-based RNA-sequencing Market Dynamics
        2.3.1 NGS-based RNA-sequencing Industry Trends
        2.3.2 NGS-based RNA-sequencing Market Drivers
        2.3.3 NGS-based RNA-sequencing Market Challenges
        2.3.4 NGS-based RNA-sequencing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top NGS-based RNA-sequencing Players by Revenue
        3.1.1 Global Top NGS-based RNA-sequencing Players by Revenue (2017-2022)
        3.1.2 Global NGS-based RNA-sequencing Revenue Market Share by Players (2017-2022)
    3.2 Global NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by NGS-based RNA-sequencing Revenue
    3.4 Global NGS-based RNA-sequencing Market Concentration Ratio
        3.4.1 Global NGS-based RNA-sequencing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-sequencing Revenue in 2021
    3.5 NGS-based RNA-sequencing Key Players Head office and Area Served
    3.6 Key Players NGS-based RNA-sequencing Product Solution and Service
    3.7 Date of Enter into NGS-based RNA-sequencing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 NGS-based RNA-sequencing Breakdown Data by Type
    4.1 Global NGS-based RNA-sequencing Historic Market Size by Type (2017-2022)
    4.2 Global NGS-based RNA-sequencing Forecasted Market Size by Type (2023-2028)
5 NGS-based RNA-sequencing Breakdown Data by Application
    5.1 Global NGS-based RNA-sequencing Historic Market Size by Application (2017-2022)
    5.2 Global NGS-based RNA-sequencing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America NGS-based RNA-sequencing Market Size (2017-2028)
    6.2 North America NGS-based RNA-sequencing Market Size by Country (2017-2022)
    6.3 North America NGS-based RNA-sequencing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe NGS-based RNA-sequencing Market Size (2017-2028)
    7.2 Europe NGS-based RNA-sequencing Market Size by Country (2017-2022)
    7.3 Europe NGS-based RNA-sequencing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific NGS-based RNA-sequencing Market Size (2017-2028)
    8.2 Asia-Pacific NGS-based RNA-sequencing Market Size by Country (2017-2022)
    8.3 Asia-Pacific NGS-based RNA-sequencing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America NGS-based RNA-sequencing Market Size (2017-2028)
    9.2 Latin America NGS-based RNA-sequencing Market Size by Country (2017-2022)
    9.3 Latin America NGS-based RNA-sequencing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa NGS-based RNA-sequencing Market Size (2017-2028)
    10.2 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2017-2022)
    10.3 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Illumina
        11.1.1 Illumina Company Detail
        11.1.2 Illumina Business Overview
        11.1.3 Illumina NGS-based RNA-sequencing Introduction
        11.1.4 Illumina Revenue in NGS-based RNA-sequencing Business (2017-2022)
        11.1.5 Illumina Recent Development
    11.2 Thermo Fischer Scientific
        11.2.1 Thermo Fischer Scientific Company Detail
        11.2.2 Thermo Fischer Scientific Business Overview
        11.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Introduction
        11.2.4 Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2017-2022)
        11.2.5 Thermo Fischer Scientific Recent Development
    11.3 Oxford Nanopore
        11.3.1 Oxford Nanopore Company Detail
        11.3.2 Oxford Nanopore Business Overview
        11.3.3 Oxford Nanopore NGS-based RNA-sequencing Introduction
        11.3.4 Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2017-2022)
        11.3.5 Oxford Nanopore Recent Development
    11.4 Agilent Technologies
        11.4.1 Agilent Technologies Company Detail
        11.4.2 Agilent Technologies Business Overview
        11.4.3 Agilent Technologies NGS-based RNA-sequencing Introduction
        11.4.4 Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2017-2022)
        11.4.5 Agilent Technologies Recent Development
    11.5 BGI
        11.5.1 BGI Company Detail
        11.5.2 BGI Business Overview
        11.5.3 BGI NGS-based RNA-sequencing Introduction
        11.5.4 BGI Revenue in NGS-based RNA-sequencing Business (2017-2022)
        11.5.5 BGI Recent Development
    11.6 PerkinElmer
        11.6.1 PerkinElmer Company Detail
        11.6.2 PerkinElmer Business Overview
        11.6.3 PerkinElmer NGS-based RNA-sequencing Introduction
        11.6.4 PerkinElmer Revenue in NGS-based RNA-sequencing Business (2017-2022)
        11.6.5 PerkinElmer Recent Development
    11.7 QIAGEN
        11.7.1 QIAGEN Company Detail
        11.7.2 QIAGEN Business Overview
        11.7.3 QIAGEN NGS-based RNA-sequencing Introduction
        11.7.4 QIAGEN Revenue in NGS-based RNA-sequencing Business (2017-2022)
        11.7.5 QIAGEN Recent Development
    11.8 Eurofins Scientific
        11.8.1 Eurofins Scientific Company Detail
        11.8.2 Eurofins Scientific Business Overview
        11.8.3 Eurofins Scientific NGS-based RNA-sequencing Introduction
        11.8.4 Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2017-2022)
        11.8.5 Eurofins Scientific Recent Development
    11.9 Roche
        11.9.1 Roche Company Detail
        11.9.2 Roche Business Overview
        11.9.3 Roche NGS-based RNA-sequencing Introduction
        11.9.4 Roche Revenue in NGS-based RNA-sequencing Business (2017-2022)
        11.9.5 Roche Recent Development
    11.10 Takara Bio
        11.10.1 Takara Bio Company Detail
        11.10.2 Takara Bio Business Overview
        11.10.3 Takara Bio NGS-based RNA-sequencing Introduction
        11.10.4 Takara Bio Revenue in NGS-based RNA-sequencing Business (2017-2022)
        11.10.5 Takara Bio Recent Development
    11.11 GENEWIZ
        11.11.1 GENEWIZ Company Detail
        11.11.2 GENEWIZ Business Overview
        11.11.3 GENEWIZ NGS-based RNA-sequencing Introduction
        11.11.4 GENEWIZ Revenue in NGS-based RNA-sequencing Business (2017-2022)
        11.11.5 GENEWIZ Recent Development
    11.12 Hamilton
        11.12.1 Hamilton Company Detail
        11.12.2 Hamilton Business Overview
        11.12.3 Hamilton NGS-based RNA-sequencing Introduction
        11.12.4 Hamilton Revenue in NGS-based RNA-sequencing Business (2017-2022)
        11.12.5 Hamilton Recent Development
    11.13 Macrogen
        11.13.1 Macrogen Company Detail
        11.13.2 Macrogen Business Overview
        11.13.3 Macrogen NGS-based RNA-sequencing Introduction
        11.13.4 Macrogen Revenue in NGS-based RNA-sequencing Business (2017-2022)
        11.13.5 Macrogen Recent Development
    11.14 Zymo Research
        11.14.1 Zymo Research Company Detail
        11.14.2 Zymo Research Business Overview
        11.14.3 Zymo Research NGS-based RNA-sequencing Introduction
        11.14.4 Zymo Research Revenue in NGS-based RNA-sequencing Business (2017-2022)
        11.14.5 Zymo Research Recent Development
    11.15 Tecan Genomics
        11.15.1 Tecan Genomics Company Detail
        11.15.2 Tecan Genomics Business Overview
        11.15.3 Tecan Genomics NGS-based RNA-sequencing Introduction
        11.15.4 Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2017-2022)
        11.15.5 Tecan Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global NGS-based RNA-sequencing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Sequencing by Synthesis
    Table 3. Key Players of Ion Semiconductor Sequencing
    Table 4. Key Players of Single-molecule Real-time Sequencing
    Table 5. Key Players of Nanopore Sequencing
    Table 6. Global NGS-based RNA-sequencing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global NGS-based RNA-sequencing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global NGS-based RNA-sequencing Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global NGS-based RNA-sequencing Market Share by Region (2017-2022)
    Table 10. Global NGS-based RNA-sequencing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global NGS-based RNA-sequencing Market Share by Region (2023-2028)
    Table 12. NGS-based RNA-sequencing Market Trends
    Table 13. NGS-based RNA-sequencing Market Drivers
    Table 14. NGS-based RNA-sequencing Market Challenges
    Table 15. NGS-based RNA-sequencing Market Restraints
    Table 16. Global NGS-based RNA-sequencing Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global NGS-based RNA-sequencing Market Share by Players (2017-2022)
    Table 18. Global Top NGS-based RNA-sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2021)
    Table 19. Ranking of Global Top NGS-based RNA-sequencing Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by NGS-based RNA-sequencing Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players NGS-based RNA-sequencing Product Solution and Service
    Table 23. Date of Enter into NGS-based RNA-sequencing Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global NGS-based RNA-sequencing Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global NGS-based RNA-sequencing Revenue Market Share by Type (2017-2022)
    Table 27. Global NGS-based RNA-sequencing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global NGS-based RNA-sequencing Revenue Market Share by Type (2023-2028)
    Table 29. Global NGS-based RNA-sequencing Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global NGS-based RNA-sequencing Revenue Market Share by Application (2017-2022)
    Table 31. Global NGS-based RNA-sequencing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global NGS-based RNA-sequencing Revenue Market Share by Application (2023-2028)
    Table 33. North America NGS-based RNA-sequencing Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America NGS-based RNA-sequencing Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe NGS-based RNA-sequencing Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe NGS-based RNA-sequencing Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America NGS-based RNA-sequencing Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America NGS-based RNA-sequencing Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Illumina Company Detail
    Table 44. Illumina Business Overview
    Table 45. Illumina NGS-based RNA-sequencing Product
    Table 46. Illumina Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
    Table 47. Illumina Recent Development
    Table 48. Thermo Fischer Scientific Company Detail
    Table 49. Thermo Fischer Scientific Business Overview
    Table 50. Thermo Fischer Scientific NGS-based RNA-sequencing Product
    Table 51. Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
    Table 52. Thermo Fischer Scientific Recent Development
    Table 53. Oxford Nanopore Company Detail
    Table 54. Oxford Nanopore Business Overview
    Table 55. Oxford Nanopore NGS-based RNA-sequencing Product
    Table 56. Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
    Table 57. Oxford Nanopore Recent Development
    Table 58. Agilent Technologies Company Detail
    Table 59. Agilent Technologies Business Overview
    Table 60. Agilent Technologies NGS-based RNA-sequencing Product
    Table 61. Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
    Table 62. Agilent Technologies Recent Development
    Table 63. BGI Company Detail
    Table 64. BGI Business Overview
    Table 65. BGI NGS-based RNA-sequencing Product
    Table 66. BGI Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
    Table 67. BGI Recent Development
    Table 68. PerkinElmer Company Detail
    Table 69. PerkinElmer Business Overview
    Table 70. PerkinElmer NGS-based RNA-sequencing Product
    Table 71. PerkinElmer Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
    Table 72. PerkinElmer Recent Development
    Table 73. QIAGEN Company Detail
    Table 74. QIAGEN Business Overview
    Table 75. QIAGEN NGS-based RNA-sequencing Product
    Table 76. QIAGEN Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
    Table 77. QIAGEN Recent Development
    Table 78. Eurofins Scientific Company Detail
    Table 79. Eurofins Scientific Business Overview
    Table 80. Eurofins Scientific NGS-based RNA-sequencing Product
    Table 81. Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
    Table 82. Eurofins Scientific Recent Development
    Table 83. Roche Company Detail
    Table 84. Roche Business Overview
    Table 85. Roche NGS-based RNA-sequencing Product
    Table 86. Roche Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
    Table 87. Roche Recent Development
    Table 88. Takara Bio Company Detail
    Table 89. Takara Bio Business Overview
    Table 90. Takara Bio NGS-based RNA-sequencing Product
    Table 91. Takara Bio Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
    Table 92. Takara Bio Recent Development
    Table 93. GENEWIZ Company Detail
    Table 94. GENEWIZ Business Overview
    Table 95. GENEWIZ NGS-based RNA-sequencingProduct
    Table 96. GENEWIZ Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
    Table 97. GENEWIZ Recent Development
    Table 98. Hamilton Company Detail
    Table 99. Hamilton Business Overview
    Table 100. Hamilton NGS-based RNA-sequencingProduct
    Table 101. Hamilton Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
    Table 102. Hamilton Recent Development
    Table 103. Macrogen Company Detail
    Table 104. Macrogen Business Overview
    Table 105. Macrogen NGS-based RNA-sequencingProduct
    Table 106. Macrogen Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
    Table 107. Macrogen Recent Development
    Table 108. Zymo Research Company Detail
    Table 109. Zymo Research Business Overview
    Table 110. Zymo Research NGS-based RNA-sequencingProduct
    Table 111. Zymo Research Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
    Table 112. Zymo Research Recent Development
    Table 113. Tecan Genomics Company Detail
    Table 114. Tecan Genomics Business Overview
    Table 115. Tecan Genomics NGS-based RNA-sequencingProduct
    Table 116. Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
    Table 117. Tecan Genomics Recent Development
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global NGS-based RNA-sequencing Market Share by Type: 2021 VS 2028
    Figure 2. Sequencing by Synthesis Features
    Figure 3. Ion Semiconductor Sequencing Features
    Figure 4. Single-molecule Real-time Sequencing Features
    Figure 5. Nanopore Sequencing Features
    Figure 6. Global NGS-based RNA-sequencing Market Share by Application in 2021 & 2028
    Figure 7. Research & Academia Case Studies
    Figure 8. Hospitals & Clinics Case Studies
    Figure 9. Pharmaceutical & Biotechnology Companies Case Studies
    Figure 10. Others Case Studies
    Figure 11. NGS-based RNA-sequencing Report Years Considered
    Figure 12. Global NGS-based RNA-sequencing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global NGS-based RNA-sequencing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global NGS-based RNA-sequencing Market Share by Region: 2021 VS 2028
    Figure 15. Global NGS-based RNA-sequencing Market Share by Players in 2021
    Figure 16. Global Top NGS-based RNA-sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by NGS-based RNA-sequencing Revenue in 2021
    Figure 18. North America NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America NGS-based RNA-sequencing Market Share by Country (2017-2028)
    Figure 20. United States NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe NGS-based RNA-sequencing Market Share by Country (2017-2028)
    Figure 24. Germany NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific NGS-based RNA-sequencing Market Share by Region (2017-2028)
    Figure 32. China NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America NGS-based RNA-sequencing Market Share by Country (2017-2028)
    Figure 40. Mexico NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa NGS-based RNA-sequencing Market Share by Country (2017-2028)
    Figure 44. Turkey NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Illumina Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
    Figure 47. Thermo Fischer Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
    Figure 48. Oxford Nanopore Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
    Figure 49. Agilent Technologies Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
    Figure 50. BGI Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
    Figure 51. PerkinElmer Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
    Figure 52. QIAGEN Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
    Figure 53. Eurofins Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
    Figure 54. Roche Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
    Figure 55. Takara Bio Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
    Figure 56. GENEWIZ Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
    Figure 57. Hamilton Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
    Figure 58. Macrogen Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
    Figure 59. Zymo Research Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
    Figure 60. Tecan Genomics Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics
Frequently Asked Questions
NGS-based RNA-sequencing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
NGS-based RNA-sequencing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
NGS-based RNA-sequencing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports